These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Linking the proteins--elucidation of proteome-scale networks using mass spectrometry. Pflieger D; Gonnet F; de la Fuente van Bentem S; Hirt H; de la Fuente A Mass Spectrom Rev; 2011; 30(2):268-97. PubMed ID: 21337599 [TBL] [Abstract][Full Text] [Related]
5. Approaches for systematic proteome exploration. Falk R; Ramström M; Ståhl S; Hober S Biomol Eng; 2007 Jun; 24(2):155-68. PubMed ID: 17376740 [TBL] [Abstract][Full Text] [Related]
6. Proteomics approaches to understand protein phosphorylation in pathway modulation. Schulze WX Curr Opin Plant Biol; 2010 Jun; 13(3):280-87. PubMed ID: 20097120 [TBL] [Abstract][Full Text] [Related]
7. Special issue in quantitative mass spectrometric proteomics. Barnouin K Amino Acids; 2012 Sep; 43(3):1005-7. PubMed ID: 22821271 [No Abstract] [Full Text] [Related]
8. Application of mass spectrometry in proteomics. Guerrera IC; Kleiner O Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421 [TBL] [Abstract][Full Text] [Related]
9. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes. Roe MR; Griffin TJ Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762 [TBL] [Abstract][Full Text] [Related]
10. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications. Balkhi MY; Trivedi AK; Geletu M; Christopeit M; Bohlander SK; Behre HM; Behre G Oncogene; 2006 Nov; 25(53):7041-58. PubMed ID: 16732326 [TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Calvo KR; Liotta LA; Petricoin EF Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423 [TBL] [Abstract][Full Text] [Related]
13. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR). Wu SL; Kim J; Hancock WS; Karger B J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266 [TBL] [Abstract][Full Text] [Related]
14. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Jones P; Côté RG; Martens L; Quinn AF; Taylor CF; Derache W; Hermjakob H; Apweiler R Nucleic Acids Res; 2006 Jan; 34(Database issue):D659-63. PubMed ID: 16381953 [TBL] [Abstract][Full Text] [Related]
15. Proteome profiling reveals potential toxicity and detoxification pathways following exposure of BEAS-2B cells to engineered nanoparticle titanium dioxide. Ge Y; Bruno M; Wallace K; Winnik W; Prasad RY Proteomics; 2011 Jun; 11(12):2406-22. PubMed ID: 21595037 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle: proteomics gives it a spin. Archambault V Expert Rev Proteomics; 2005 Aug; 2(4):615-25. PubMed ID: 16097893 [TBL] [Abstract][Full Text] [Related]
19. Quantitative mass spectrometry-based proteomics: an overview. Nikolov M; Schmidt C; Urlaub H Methods Mol Biol; 2012; 893():85-100. PubMed ID: 22665296 [TBL] [Abstract][Full Text] [Related]
20. [Functional proteomics in oncology: to understand more than to describe]. Com E; Hondermarck H Med Sci (Paris); 2007 Mar; 23 Spec No 1():27-30. PubMed ID: 17669350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]